We analyzed the harvested tumors at the termination of the experiment to evaluate the effect of ALDH1A3 knockdown and 2DG treatment on the percentage of CD24−CD44+ cells and the tumor-initiating cell frequency. The gene discussed is ALDH1A3; the disease is neoplasm.